New York State Common Retirement Fund
CMPX icon

New York State Common Retirement Fund’s Compass Therapeutics CMPX Stock Holding History

New York State Common Retirement Fund’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.6K Hold
30,407
– – ﹤0.01% 2880
2026
Q1 		$161K Hold
30,407
– – ﹤0.01% 2322
2025
Q4 		$163K Hold
30,407
– – ﹤0.01% 2371
2025
Q3 		$106K Hold
30,407
– – ﹤0.01% 2590
2025
Q2 		$79.1K Hold
30,407
– – ﹤0.01% 2807
2025
Q1 		$57.8K Sell
30,407
-7,800
-20% -$20.7K ﹤0.01% 2724
2024
Q4 		$55.4K Hold
38,207
– – ﹤0.01% 2829
2024
Q3 		$70.3K Hold
38,207
– – ﹤0.01% 2748
2024
Q2 		$38.2K Buy
38,207
+130
+0.3% +$190 ﹤0.01% 3145
2024
Q1 		$75.4K Sell
38,077
-104
-0.3% -$180 ﹤0.01% 2846
2023
Q4 		$59.6K Sell
38,181
-180
-0.5% -$311 ﹤0.01% 2942
2023
Q3 		$75.6K Buy
38,361
+961
+3% +$2.38K ﹤0.01% 2861
2023
Q2 		$119K Buy
+37,400
New +$117K ﹤0.01% 2712

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

New York State Common Retirement Fund's CMPX Position: Q2 2026 in Review

New York State Common Retirement Fund held its Compass Therapeutics (CMPX) position steady in Q2 2026 at 30,407 shares worth $66.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2880.

New York State Common Retirement Fund first reported a position in CMPX in Q2 2023 and has held it in 13 quarters since. The position peaked at $163K in Q4 2025. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • New York State Common Retirement Fund held 30,407 shares of Compass Therapeutics worth $66.6K as of Q2 2026.
  • New York State Common Retirement Fund left its Compass Therapeutics share count unchanged in Q2 2026.
  • Compass Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2880 holding.
  • New York State Common Retirement Fund first reported a position in Compass Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • New York State Common Retirement Fund's Compass Therapeutics position peaked at $163K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.